Based on Phase 2 data, retatrutide produced slightly greater weight loss than tirzepatide in a shorter trial duration
Questions We've got answers
GLP-1 is a gut-derived insulin agonist with the ability to suppress glucagon release and stimulate insulin secretion through targeting -cells and -cells, respectively [5]
Cognitive & Circadian Restoration It has shown potential to reduce neuroinflammatory cytokines (e.g., TNF-, IL-6) and stabilize circadian gene oscillations, which may benefit sleep, mood, and cognitive clarity
Food and Drug Administration has taken action against products of this type rather than authorising them
Cigna Medicare Advantage Blocked by Law If you're on Medicare, federal law says Medicare cannot pay for weight-loss drugs